together we are stronger than the disease

Let’s accelerate metastatic breast cancer research together.

MBC Connect is an interactive, web and mobile-friendly patient registry, where you can share information about your MBC disease history, experiences, and quality of life.

MBC Alliance Publishes Third Article in our Epidemiology Series

New Study Shows a Decline in the Incidence of Recurrent Metastatic Breast Cancer Over Time
but no Improvement in Survival

New York, NY (February 1, 2019) A retrospective analysis – reported in the journal Breast Cancer Research and Treatment, by Judith Malmgren, PhD, and co-authors – studied 8292 women with stage I-III invasive breast cancer, 964 of whom (11.6%) were later diagnosed with recurrent metastatic breast cancer (rMBC). The authors found a significant decline in rMBC over time, but no increase in survival. Survival after an rMBC diagnosis decreased over time, from 23% in the years between 1990 and 1998, to 21% between 1999 and 2004, and to 13% between 2005 and 2011.

Welcome to the Precision Medicine* Revolution

*PRECISION MEDICINE is a form of medicine that uses information about a person’s genes, proteins, and environment to prevent, diagnose, and treat disease. In cancer, precision medicine uses specific information about a person’s tumor to help diagnose, plan treatment, find out how well treatment is working, or make a prognosis. Examples of precision medicine include using targeted therapies to treat specific types of cancer cell, such as HER2-positive breast cancer cells, or using tumor marker testing to help diagnose cancer.
Also called personalized medicine.